C-MER Medical Holdings Beheer
Beheer criteriumcontroles 2/4
Momenteel beschikken wij niet over voldoende informatie over de CEO.
Belangrijke informatie
Dennis Lam
Algemeen directeur
HK$6.0m
Totale compensatie
Percentage CEO-salaris | 95.7% |
Dienstverband CEO | no data |
Eigendom CEO | 0.9% |
Management gemiddelde ambtstermijn | geen gegevens |
Gemiddelde ambtstermijn bestuur | 5.5yrs |
Recente managementupdates
Recent updates
Returns On Capital Signal Tricky Times Ahead For C-MER Medical Holdings (HKG:3309)
Nov 13Is C-MER Medical Holdings (HKG:3309) A Risky Investment?
Oct 18Not Many Are Piling Into C-MER Medical Holdings Limited (HKG:3309) Stock Yet As It Plummets 27%
Sep 04Shareholders Will Probably Hold Off On Increasing C-MER Eye Care Holdings Limited's (HKG:3309) CEO Compensation For The Time Being
May 21C-MER Eye Care Holdings' (HKG:3309) Earnings May Just Be The Starting Point
Apr 29C-MER Eye Care Holdings Limited's (HKG:3309) 26% Share Price Plunge Could Signal Some Risk
Feb 02C-MER Eye Care Holdings (HKG:3309) Might Be Having Difficulty Using Its Capital Effectively
Jan 17A Look At The Intrinsic Value Of C-MER Eye Care Holdings Limited (HKG:3309)
Apr 24Capital Allocation Trends At C-MER Eye Care Holdings (HKG:3309) Aren't Ideal
Dec 04Is C-MER Eye Care Holdings (HKG:3309) A Risky Investment?
Sep 22Update: C-MER Eye Care Holdings (HKG:3309) Stock Gained 25% In The Last Year
Dec 07Analyse CEO-vergoeding
Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
---|---|---|---|
Jun 30 2024 | n/a | n/a | HK$63m |
Mar 31 2024 | n/a | n/a | HK$63m |
Dec 31 2023 | HK$6m | HK$6m | HK$62m |
Sep 30 2023 | n/a | n/a | HK$28m |
Jun 30 2023 | n/a | n/a | -HK$7m |
Mar 31 2023 | n/a | n/a | -HK$14m |
Dec 31 2022 | HK$6m | HK$6m | -HK$22m |
Sep 30 2022 | n/a | n/a | HK$545k |
Jun 30 2022 | n/a | n/a | HK$23m |
Mar 31 2022 | n/a | n/a | HK$22m |
Dec 31 2021 | HK$6m | HK$6m | HK$22m |
Sep 30 2021 | n/a | n/a | HK$25m |
Jun 30 2021 | n/a | n/a | HK$28m |
Mar 31 2021 | n/a | n/a | HK$11m |
Dec 31 2020 | HK$4m | HK$4m | -HK$6m |
Sep 30 2020 | n/a | n/a | -HK$10m |
Jun 30 2020 | n/a | n/a | -HK$13m |
Mar 31 2020 | n/a | n/a | HK$14m |
Dec 31 2019 | HK$1m | HK$1m | HK$41m |
Sep 30 2019 | n/a | n/a | HK$53m |
Jun 30 2019 | n/a | n/a | HK$64m |
Mar 31 2019 | n/a | n/a | HK$53m |
Dec 31 2018 | HK$1m | HK$1m | HK$43m |
Sep 30 2018 | n/a | n/a | HK$35m |
Jun 30 2018 | n/a | n/a | HK$27m |
Mar 31 2018 | n/a | n/a | HK$31m |
Dec 31 2017 | HK$4m | HK$3m | HK$40m |
Compensatie versus markt: De totale vergoeding ($USD 773.46K ) Dennis } ligt boven het gemiddelde voor bedrijven van vergelijkbare omvang in de Hong Kong markt ($USD 392.73K ).
Compensatie versus inkomsten: De vergoeding van Dennis is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.
CEO
Dennis Lam (64 yo)
no data
Tenure
HK$6,018,000
Compensatie
Dr. Shun Chiu Lam, JP, also known as Dennis, serves as Chairman and Chief Executive Officer of C-MER Medical Holdings Limited (formerly known as C-MER Eye Care Holdings Limited). Dr. Lam is also a director...
Bestuursleden
Naam | Positie | Tenure | Compensatie | Eigendom |
---|---|---|---|---|
Chairman & CEO | no data | HK$6.02m | 0.95% HK$ 23.5m | |
Executive Director | 7.4yrs | HK$3.81m | geen gegevens | |
Head of Hong Kong Operation & Executive Director | 7.4yrs | HK$240.00k | 1.08% HK$ 26.8m | |
Independent Non-Executive Director | 6.9yrs | HK$240.00k | geen gegevens | |
Independent Vice Chairman of the Board | 4yrs | HK$759.00k | 0.024% HK$ 609.1k | |
Independent Non-Executive Director | 1.3yrs | HK$120.00k | geen gegevens | |
Independent Non-Executive Director | 4yrs | HK$240.00k | geen gegevens |
5.5yrs
Gemiddelde duur
64yo
Gemiddelde leeftijd
Ervaren bestuur: De raad van bestuur van 3309 wordt beschouwd als ervaren (gemiddelde ambtstermijn 5.5 jaar).